View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

Omnicare to pay $124 million to settle fraud allegations

Cincinnati-based Omnicare Inc. is to pay more than $124 million in a settlement with the U.S. Department of Justice for allegedly offering financial incentives to healthcare facilities.
Read More

India's drug makers embrace automation

India's second largest drug maker by sales, Dr. Reddy's Laboratories, is embracing automation and making it a critical part of the manufacturing process.
Read More

US regulator to tighten scrutiny on potential drug delay deals

The U.S. Federal Trade Commission has announced plans to increase probes into pharmaceutical deals that potentially harm competition by delaying the launch of generic drugs on the market.
Read More

British scientists discover way to fight antibiotic-resistant bacteria

Thanks to a new study by researchers at the University of East Anglia (UEA), the fight against antibiotic-resistant bacteria may become easier.
Read More

Merck to take over hepatitis C drug maker

American pharmaceutical giant Merck & Co. is planning to buy Idenix Pharmaceuticals Inc., a Massachusetts-based company specializing in developing treatment for hepatitis C.
Read More

Hikma Pharmaceuticals to take over US generic injectables manufacturer

London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.
Read More

US pharma major Abbott to pay $2.9 billion for Chile's CFR

U.S. pharmaceuticals and healthcare products major Abbott Laboratories has agreed to acquire Chile-based pharmaceutical firm CFR Pharmaceuticals SA in a deal worth $2.9 billion.
Read More

Sun Pharma's response to FDA import ban seen as 'inadequate'

According to the U.S. Food and Drug Administration, Sun Pharma has failed to take sufficient measures to correct the violations that led to the enforcement action.
Read More

EU, US health officials team up to fight antimicrobial resistance

Health officials from both sides of the Atlantic have been working together to tackle antimicrobial resistance under their joint Transatlantic Taskforce on Antimicrobial Resistance.
Read More

Sanofi looking to shed multi-billion portfolio to optimize assets

French pharmaceutical giant Sanofi SA is exploring options to sell a range of older drugs, with an estimated value of the portfolio between $7 billion and $8 billion.
Read More